Deutsche Bank has lowered its price target for Molina Healthcare (MOH) from $165 to $109, while maintaining a Hold rating on the stock. This adjustment reflects a more cautious outlook on the managed healthcare company. Other analysts, including Barclays, UBS, Cantor Fitzgerald, and Jefferies, have also recently revised their price targets lower for Molina Healthcare.
This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
Deutsche Bank Cuts Price Target on Molina Healthcare to $109 From $165, Keeps Hold Rating
Deutsche Bank has lowered its price target for Molina Healthcare (MOH) from $165 to $109, while maintaining a Hold rating on the stock. This adjustment reflects a more cautious outlook on the managed healthcare company. Other analysts, including Barclays, UBS, Cantor Fitzgerald, and Jefferies, have also recently revised their price targets lower for Molina Healthcare.